Little Green Pharma Ltd (ASX:LGP)
0.1050
-0.0100 (-8.70%)
Jul 11, 2025, 3:59 PM AEST
Little Green Pharma Revenue
In the fiscal year ending March 31, 2025, Little Green Pharma had annual revenue of 36.86M AUD with 35.07% growth. Little Green Pharma had revenue of 19.33M in the half year ending March 31, 2025, with 80.64% growth.
Revenue
36.86M
Revenue Growth
+35.07%
P/S Ratio
0.87
Revenue / Employee
n/a
Employees
94
Market Cap
31.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 36.86M | 9.57M | 35.07% |
Mar 31, 2024 | 27.29M | 7.43M | 37.41% |
Mar 31, 2023 | 19.86M | 5.82M | 41.45% |
Mar 31, 2022 | 14.04M | 7.04M | 100.47% |
Jun 30, 2021 | 7.00M | 4.80M | 217.77% |
Jun 30, 2020 | Pro | Pro | Pro |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Regis Healthcare | 1.10B |